ISSN 2284-6808 Letters in Applied NanoBioScience
Transcript of ISSN 2284-6808 Letters in Applied NanoBioScience
Page | 908
In silico toxicity prediction, synthesis, characterization, antimicrobial and
antioxidant activity of different di substituted chalcones
Shaik Ammaji 1, *
, Cheekurthi Sunddep 1, Koduru Sandeep
1, Kunchala Ashok
1, Kancharala Praveen
1,
Badugu Sai Murali 1
1 NRI College of Pharmacy, pothavarapadu, agiripalli, Vijayawada, Krishna (Dt), Andhra Pradesh. *corresponding author e-mail address: [email protected]
ABSTRACT
Right now the amalgamation of novel arrangement of 4'- chloro-3'- nitro-phenyl-(3-keto-1,2diene-1-flurobenzene), 4'- chloro-3'nitro-
phenyl-(3-keto-1,2diene-1-chlorobenzene),4'- chloro-3'- nitro-phenyl-(3-keto-1,2diene-1-thiophene),4'- chloro-3'nitro-phenyl-(3-keto-
1,2diene-1-pyridine), 4'- chloro-3'nitro-phenyl-(3-keto-1,2diene-1-furon).The target mixes were integrated by the Claisen-schimidt
buildup utilizing corrosive and base as a response impetus. insilico enhancement strategies by utilization of various information base like
molinspiration for atomic properties, bioactivity, ochem for organic information, pre ADME for pharmacokinetic properties, preToxicity
for harmfulness profile of the mixes, swiss ADME for pharmacokinetic property, Swiss lethality for natural danger of the mixes, and
Osiris(datawarrior) for poisonous quality forecast for dynamic lead particles ID. From the outcome mixes indented as dynamic leads they
used to assess distinctive organic action. The mixes additionally finish the amees assessment for the most part for mutagenecity
discovery that mixes shows mutagencity towards the test living being they likewise safe to hinder cytochrome P450 compound subunits
like cyp1A2, cyp2C9, cyp2C19 which are situated in endoplasmic reticulum. Alpha beta unsaturated chalcones have fantastic cell
reinforcement and antimicrobial action so the orchestrated mixes were screened for their antimicrobial by utilizing five bacterial strains
and three parasitic strains and cancer prevention agent action by DPPH technique. From hostile to oxidant results compound 3a, 3b, 3c
show critical action the measure esteems are closer to standard medication esteem. Antimicrobial movement results the compound 3a,
3c, 3e indicated noteworthy action against Bacillus subtilis, E Coli, Salmonella tyhphi, Pseudomonas aeruginosa though the compound
3b, 3d demonstrated moderate activitycompared to standard medication vale. Compound 3b, 3d demonstrated fantastic antifungal action
against Candida albicans, Aspergillusniger, Alternariaalternata. The mixes 3a, 3c, 3e show moderate antifungal movement when
contrasted with standard worth.
Keywords:molinspiration; Osiris; ochem; preADME; antioxidant; antimicrobial activity.
1. INTRODUCTION
Chalcones are α,βunsaturated ketone they are focal center
for acombined assortment of organic mixes. Claisen-Schmidt
buildup between aromatic ketone and fragrant aldehyde to give
chalcone the response catalyzed by corrosive and base under
homogeneous or heterogeneous conditions [1,2] they are open
chain antecedent particle for biosynthesis of flavanoids,
isoflavnoids and poly phenolic derivatives[3]. They exist as two
isomeric structures cis and trans. Trans ismore steady than cis
structure [4]. The mixes have enormous no of replaceable
hydrogen particles that permit to blended a huge assortment of
subordinates like pyrazoles, imidazole, thiazole, triazole, oxazole
and so on, they show distinctive kind of organic exercises like
antigout [6], hostile to histamine [7], antioxidant [8], antiodesity
[9], hypotics [10], antispasmodic [11], antiprotozal [10] and so on.
These days, various similar pharmacological examinations of the
chalcones have indicated great cancer prevention agent movement
with low reactions. In past reports the greater part of the chalcones
integrated by utilizing single subbed ketone with single or di
subbed aldehydes however right now di subbed ketone with
various subbed aldehydes utilized for blend of various chalcone
subsidiaries.
2. MATERIALS AND METHODS
2.1. Materials.
All the chemicals and reagents were obtained in synthetic
grade from commercial sources. Microwave irradiation was
carried out in LG domestic microwave oven. Reaction was
monitorby TLC (silica gel). 4’Chloro-3’nitro MKBX1257V Sigma
Aldrich Acetophenone, Potassium hydroxide N1400361 Avra
synthesis (85%) P-Chlorobenzaldehyde L126101406 Loba
chemic, 2-Fluorobenzaldehyde A301696 Spectro chem., 2-
Furaldehyde (99%) N1601838 Avra synthesis Pyridine-4-
carboxalde N1602027 Avra synthesis -hyde(98%) 3-
Fluorobenzaldehyde N1610254 Avra synthesis (98%) 3-
Chlorobenzaldehyde B300201 Spectro chem., 2-
Thiophenecarboxalde N1703574 Avra synthesis- hyde(98%), 2-
Chlorobenzaldehyde N1810073 Avra synthesis, 4-
Fluorobenzaldehyde N1800433 Avra synthesis (98%)3-Hydroxy
benzaldehyde N1701409 Avra synthesis (97%)2-
Hydroxybenzaldehyde N1800578 Avra synthesis (98%) 4-
Hydroxybenzaldehyde N1800160 Avra synthesis.
2.2. Method.
2.2.1. Synthesis of Chalcones.
A mixture of ketone (0.05mol), appropriate aldehyde
(0.05mol) and 10% aqueous sodium hydroxide (10ml) in ethanol
Volume 9, Issue 1, 2020, 908 - 913 ISSN 2284-6808
Open Access Journal Received: 04.03.2020 / Revised: 18.03.2020 / Accepted: 18.03.2020 / Published on-line: 21.03.2020
Original Research Article
Letters in Applied NanoBioScience https://nanobioletters.com/
https://doi.org/10.33263/LIANBS91.908913
In silico toxicity prediction, synthesis, characterization, antimicrobial and antioxidant activity of different di substituted
chalcones
Page | 909
(30ml) should be stirred at room temperature for about 3-24 h. The
reaction mixture after achieving the desired spot in the TLC
should transfer into crushed ice to form the precipitate. The
precipitate should be filtered, washed with distilled water and
recrystallized with chloroform.
Figure 1. Synthesis of chalcones.
2.2.2. Antimicrobial activity.
Antibacterial action of the combined mixes was tried
against five bacterial strains and three parasitic strains utilizing
agar well dispersion technique [15-18]. Dimethyl sulfoxide was
utilized as dissolvable control. The bacterial culture was
vaccinated on supplement agar and contagious culture was
immunized on potato dextrose agar media (20 ml). The test mixes
were broken up in DMSO to get a convergence of 12.79M and 100
µL of this example was stacked into the wells of agar plates
legitimately. Plates immunized with the microorganisms were
brooded at 37°C for 24 h and the parasitic culture was hatched at
25°C for 72 h. All conclusions were done in triplicates. The
Streptomycin (1.71M and 0.85M) and Griseofulvin (3.26M and
1.6M) were utilized as standard medications for antibacterial and
antifungal exercises individually. After the brooding time frame,
the base restraint zone at which the microorganism development
was hindered was estimated in µg/mL [19-24].
2.2.3. Antioxidant activity Free radical scavenging activity by
DPPH method.
Free radicalscavenging capacities of synthesized
compounds were determined according to the reported procedure
[25-28]. The newly synthesized compounds at different
concentrations (25-100 µg/mL) were added to each test tube and
volume was made up to 4 ml using methanol. To this, 3 ml of
0.004% DPPH in methanol was added and the mixtures were
incubated at room temperature under dark condition for 30 min.
The absorbance was recorded at 517 nm using UV Visible
spectrophotometer (Shimadzu UV-1800, Japan).
Butylatedhydroxy toluene (BHT), dissolved in distilled water was
used as a reference [29-31]. The control sample was prepared
using the same volume without any compound and BHT, 95%
methanol served as blank. Test was performed in triplicate and the
results were averaged [32-36].
Radical scavenging activity was calculated using the formula:
Percentage of radical scavenging activity = [(Acontrol–Atest)/Acontrol]
× 100
Where Acontrol is the absorbance of the control sample (DPPH
solution without test sample) and Atest is the absorbance of the test
sample (DPPH solution+test compound).
3. RESULTS
3.1. Spectral analysis.
1-(4-chlro-3-noitrophenyl)-3-(4-fluorophenyl)pro-2-ene-1-one,
(3a), Percentage yield: 85%, m.p:14.-142oC; IR (KBr cm-1) 689
(C-Cl), 1024 (C-F), 1545 (NO2), 1649 (C=O); 1 HNMR (CDCl3
400Mz), δ (ppm) 7.65 (d 1H HαJ= 16.1Hz), 7.91 (d IH HβJ=
15.1Hz), 7.21-8.07 (m Ar-H); 13 CNMR (400MHz CDCl3), δ
(ppm), 121.3 (C-2), 145.1 (C-3), 189.7 (C=O, C-1), 124.9-148.1
(C-1’- C-6’ aromatic carbons), 115.4-162.1 (C-1’’-C-6’’ aromatic
carbons); LCMS: m/z: 305, (M+1=99.08); elemental analy: C15
H9ClFNO3, C-58.94, N-4.59, H-2.97 found C-58%, N-4.5%, H-
2.9%.
1-(4-chlro-3-noitrophenyl)-3-(2-chlorophenyl)pro-2-ene-1-one,
(3b), Percentage yield: 80%, m.p:130-135oC; IR (KBr cm-1) 684
(C-Cl), 689 (C-Cl), 1547 (NO2), 1649 (C=O); 1 HNMR (CDCl3
400Mz), δ (ppm) 7.63 (d 1H HαJ= 16.5Hz), 7.89 (d IH HβJ=
16.1Hz), 7.21-8.10 (m Ar-H); 13 CNMR (400MHz CDCl3), δ
(ppm), 121.3 (C-2), 145.1 (C-3), 189.7 (C=O, C-1), 124.9-148.9
(C-1’- C-6’ aromatic carbons), 126.7-134.0 (C-1’’-C-6’’ aromatic
carbons); LCMS: m/z: 321, (M+1=99.08); elemental analy: C15
H9Cl2NO3, C-55.9, N-4.35, H-2.82 found C-56%, N-4.0%, H-
2.5%.
1-(4-chlro-3-noitrophenyl)-3-(thiophen)pro-2-ene-1-one, (3c),
Percentage yield: 80%, m.p:120-125oC; IR (KBr cm-1) 687 (C-
Cl), 775 (C-S-C), 1547 (NO2), 1649 (C=O); 1 HNMR (CDCl3
400Mz), δ (ppm) 7.63 (d 1H HαJ= 16.5Hz), 7.85 (d IH HβJ=
16.1Hz), 7.21-8.15 (m Ar-H); 13 CNMR (400MHz CDCl3), δ
(ppm), 121.3 (C-2), 134.1 (C-3), 189.7 (C=O, C-1), 129.1-140.3
(C-1’’-C-4’’thiophen carbons), 130.2-148.1 (C-1’- C-6’ aromatic
carbons); LCMS: m/z: 292, (M+1=99.08); elemental analy: C15
H10ClNO3S, C-53.1, N-4.77, H-2.75 found C-53%, N-4.7%, H-
2.5%.
1-(4-chlro-3-noitrophenyl)-3-(pyridine)pro-2-ene-1-one, (3d),
Percentage yield: 85%, m.p:95-98oC; IR (KBr cm-1) 689 (C-Cl),
1547 (NO2), 1640 (C=N), 1649 (C=O); 1 HNMR (CDCl3 400Mz),
δ (ppm) 7.65 (d 1H HαJ= 15.5Hz), 7.80 (d IH HβJ= 16.1Hz),
7.21-8.27 (m Ar-H); 13 CNMR (400MHz CDCl3), δ (ppm), 127.0
(C-2), 143.4 (C-3), 189.7 (C=O, C-1), 122.7-154.7 (C-1’’-C-5’’
pyridine carbons), 124.9-148.1 (C-1’- C-6’ aromatic carbons);
LCMS: m/z: 288, (M+1=99.04); elemental analy: C14 H9ClN2O3;
C-58.2, N-9.77, H-3.14 found C-58%, N-9.7%, H-3.0%.
1-(4-chlro-3-noitrophenyl)-3-(furan)pro-2-ene-1-one, (3e),
Percentage yield: 80%, m.p:120-125oC; IR (KBr cm-1) 686 (C-
Cl), 1545 (NO2), 1649 (C=O); 1 HNMR (CDCl3 400Mz), δ (ppm)
7.63 (d 1H HαJ= 16.5Hz), 7.85 (d IH HβJ= 16.1Hz), 7.21-8.15 (m
Ar-H); 13 CNMR (400MHz CDCl3), δ (ppm), 120.9 (C-3), 127.3
(C-2), 189.7 (C=O, C-1), 112.7-151.5 (C-1’’-C-4’’ furan carbons),
124.9-148.1 (C-1’- C-6’ aromatic carbons); LCMS: m/z: 292,
(M+1=99.08); elemental analy: C13 H8ClNO4; C-56.23, N-5.04, H-
2.90 found C-56.2%, N-5.0%, H-2.5%.
3.2. In silico and toxicity prediction.
Insilico toxicity prediction for synthesized compounds
carried out by using four online soft wares Molinspiration -
www.molinspiration.com; www.swissadme.ch.in,
https://ochem.eu , www.organic-chemistry.org/prog/peo/tox.html.
Shaik Ammaji, Cheekurthi Sunddep, Koduru Sandeep, Kunchala Ashok, Kancharala Praveen, Badugu Sai Murali
Page | 910
Table 1.Molinspiration results of physicochemical properties of di substituted chalcones.
COMP ID MW clogP n AH n DH TPSA n rotb
3A 305 4.03 4 0 62.9 4
3B 322 4.31 3 0 62.8 4
3C 293 3.58 3 0 62.8 4
3D 288 2.51 4 0 88.19 4
3E 277 2.94 4 0 75.7 4
MW, molecular weight; nDH, number of H-bond donors; nAH, number of H-bond acceptors; TPSA, topological polar surface area; cLogP,
Partition coefficient.
Table 2. Molinspiration bioactive score value of disubstitutedchalcones.
COMP
ID
GPCR
ligand
Ion channel
modulator
kinase
inhibitor
Nuclear
receptor ligand
protease
inhibitor
enzyme
inhibitor
3A -0.4 -0.29 -0.4 -0.26 -0.45 -0.18
3B -0.43 -0.32 -0.56 -0.27 -0.52 -0.28
3C -0.7 -0.55 -0.58 -0.55 -0.69 -0.36
3D -0.2 -0.19 -0.24 -0.44 -0.39 -0.03
3E -0.77 -0.76 -0.86 -0.62 -0.92 -0.46
If bioactivity score is >0, it is an active compound while <-5.0 is an inactive compound and range between -5.0 to 0.0 is
moderately active compounds.
Table 3. preADMET results of disustitutedchalcones.
COMP ID HIA (%) In vitro
Caco2(nm/sec)
MDCK
(nm/sec)
PPB BBB CYP 2C9, 19
3a 98.4 15.1 0.43 96.8 0.25 INHIBITOR
3b 98.4 7.2 6.94 95.5 0.039 INHIBITOR
3c 96.6 1.18 1.47 96.8 1.44 INHIBITOR
3d 97.1 8.4 4.93 94.6 0.03 INHIBITOR
3e 95.3 2.16 3.55 98.8 1.38 INHIBITOR
HIA(%), Percentage human intestinal absorption; PCaco2 (nm/sec), Caco2 cell permeability in nm/sec; MDCK (nm/sec), Madin-Darby
canine kidney cell permeabity in nm/sec; PPB(%), in vitro plasma protein binding (percentage); BBB, in vivo Blood-Brain Barrier
penetration.
Table 4. preADMET toxicity values of di substituted chalcones.
ID algae_at Ames_test TA100_1
0RLI
TA100_NA TA1535_1
0RLI
TA1535_NA Carcino_
Mouse
Carcino_R
at
3a 0.026515 mutagen Positive negative Negative Positive Positive Negative
3b 0.015208 mutagen Positive negative Positive Positive Positive Negative
3c 0.0310418 mutagen Positive negative Negative Negative Positive Negative
3d 0.0651226 mutagen Positive positive Negative Positive Positive Negative
3e 0.0611501 mutagen Positive negative Positive Negative Positive Negative
mutagenicity of amessalmonealla TA100, TA98, TA1535 Species result positive (+) shows compound is mutagenic negative (-) means non
mutagenic. In rodent carcinogenicity 2 years assay of rat and mouse by backward elimination and Rprop neural net method result Negative (-)
indicate non carcinogenic, positive (+) indicate carcinogenic.
Table 5. OCHEM chemical and biological data of di substituted chalcones.
Comp ID Ames CYP1A2 CYP2C9 CYP2C19
CYP2D6
CYP3A4 Melting
point(0c)
pyrolsis point
(celsius)
3a Active + + + + - 140 180
3b Active + + + - - 130 180
3c Active + + + - - 120 180
3d Active + + + - - 95 180
3e Active + + + - - 92 170
ames test used to determine mutagenicity of the sample result inactive means not shows any mutational change in test organism, CYP1A2,
2C9, 2C19, 2D6, 3A4 enzyme inhibition from the above results positive (+) means enzyme inhibiting property, negative (-) means drug does
not inhibit the enzyme, by using these software tool also determine the melting point and pyrolsis point (chemical decomposition of organic
material by application of heat) of the compounds.
Table 6 . Swiss physicochemical properties and bioactive score values of substituted chalcones.
comp id MW No of heavy
atoms
no of hydrogen
aceptors
no of hydrogen
donars
no of rotable
bonds
Log P Log S TPSA
3A 305 21 4 0 4 4.03 -4.57 62.9
3b 322 21 3 0 4 4.31 -5.82 62.8
3c 293 19 3 0 4 3.58 -5.02 88.19
3d 288 20 4 0 4 2.51 -4.37 75.7
3e 277 19 4 0 4 2.94 -4.82 76
Description: Swiss ADME web tool predict the molecular weight, no of heavy atoms present in the molecule, no ofhydrogen acceptors, hydrogen
donar, Log P (partition coeffient) , Log S(Solubility), TPSA, topological polar surface area. Lipinski, Ghose and Veber rules states that most
molecules with good membrane permeability have logP ≤ 5, logS ≤ 5, molecular weight ≤500, number of hydrogen bond acceptors ≤10, and
number of hydrogen bond donors ≤ 5, topological polar surface area (TPSA) < 140 Ǻ2 and number of rotatable bonds (n rotb) < 10.
In silico toxicity prediction, synthesis, characterization, antimicrobial and antioxidant activity of different di substituted
chalcones
Page | 911
Table 7 . Swiss pharmacokinetic properties of di substituted chalcones.
Comp id
GI Absortion BBR CYP
1A2
CYP2
C9
CYP2C
19
CYP2D
6
CYP3
A4
Log Kp (skin
permeation) cm/sec
Lipinsk bioavailbilit
y score
3a high yes + + + + - -5.11 yes 0.55
3b high yes + + + - + -5.11 yes 0.55
3c high yes + + + - + -5.11 yes 0.55
3d high yes + + + - - -4.83 yes 0.55
3e high yes + + + - - -4.83 yes 0.55
Description: This tool used to determine pharmacokinetic properties like GI absorption, BBR, CYP1A2, 2C9, 2D6, 3A4. From the above result yes
means molecule have enzyme inhibiting property, No means molecule not having the enzyme inhibiting property, Log kp(skin permeability) , lipinsk,
bioavailability Score.The bioactivity scores (≥ 0.00) may refer to considerable biological active compound, if the bioactivity scores (-5.0 to 0.0) it is
moderately active and finally if the bioactivity scores (< -5.0) it is inactive.
Table 8. Swiss percentage inhibition of di substituted chalcones. comp
id
enzyme GPCR Oxidoredu
ctase
Prot
ease
lignad
gated ion
channel
primary
active
transport
other cytosolic
protein
nuclear
recepto
r
kinase ligase cytochrome
P450
voltage
gated ion
channel
suface
antigen
3a 20 20 13.3 6.7 26.7 6.7 6.7 0 0 0 0 0 0
3b 20 20 13.3 6.7 26.7 6.7 6.7 0 0 0 0 0 0
3c 20 20 13.3 6.7 26.7 6.7 6.7 0 0 0 0 0 0
3d 13.3 6.7 20 6.7 13.3 6.7 0 0 6.7 0 20 0 0
3e 13.3 6.7 20 6.7 13.3 6.7 0 0 6.7 0 20 0 0
Table 9. Osiris (data warrior) molecular properties of di substituted chalcones.
comp id MW no of hydrogen
acceptors
no of hydrogen
donars
no of rotable
bonds
cLog P cLog S TPSA
DL
3A 305 4 0 4 4.03 -4.57 62.9 5.03
3b 322 3 0 4 4.31 -5.82 62.8 4.94
3c 297 3 0 4 3.58 -5.02 88.19 3.58
3d 288 4 0 4 2.51 -4.37 75.7 5.01
3e 277 4 0 4 2.94 -4.82 76 4.92
Drug- likeness. According to Lipinski rule cLog p ≤5, Clog S<-5, MW ≤500, nALH ≤10, and nDLH ≤5 drug likness(DL) >4.
Table 10. Osiris (data warrior) toxicity prediction of di substituted chalcones.
CompCode MU TU RE IR
3A None None None None
3B None None None None
3C None None None None
3D None None None None
3E None None None None
Toxicity like mutagenic, tumorigenic, irritant and reproductive risks were also predicted using OSIRIS Property. From the results of insilico
data bases all the compounds are non carcinogenic, toxicity free molecule inhibit CYP 2C9, 2C19 enzymes act as active lead molecule.
Table 11. Antibacterial activity results of synthesized compounds (3a-3e.).
Zone of inhibition in mm(SD±Mean)
Comp id Concentration(mg/ml) S. a ± S.D* B. s ±S.D* E. c ± S.D* S. t ± S.D* P. a ±S.D*
3a 1.0 20 ± 0.11 18 ± 0.16 16 ± 0.15 11 ± 0.18 12 ± 0.14
3b 1.0 14 ± 0.12 14 ± 0.60 13 ± 0.21 9 ± 0.12 ± 0.16 00
3c 1.0 15 ± 0.15 12 ± 0.16 14 ± 0.21 13 ± 0.15 13 ± 0.16
3d 1.0 13 ± 0.16 14 ± 0.16 12 ± 0.19 15 ± 0.10 12 ± 0.18
3e 1.0 21 ± 0.16 18 ± 0.13 16 ± 0.17 13 ± 0.18 13 ± 0.15
streptomycin 24 ± 0.16 21 ± 0.12 18 ± 0.11 16 ± 0.19 15 ± 0.14
Each value is the mean of three replicate determinations ± standard deviation; S. a - Staphylococcus aureus;
B. s Bacillus subtilis; E. c - Escherichia coli; S. t - Salmonella tyhphi; P. a - Pseudomonas aeruginosa
Table 12. Antifungal activity results of synthesized compounds (3a-3e).
Comp id Concentration(mg/ml) C. a ± S.D* A. n ± S.D* A. a ± S.D*
3a 1.0 10 ± 0.14 11 ± 0.16 8 ± 0.12
3b 1.0 12 ± 0.15 16 ± 0.18 10 ± 0.15
3c 1.0 10 ± 0.17 11 ± 0.19 12 ± 0.12
3d 1.0 13 ± 0.16 17 ± 0.11 13 ± 0.19
3e 1.0 10 ± 0.15 12 ± 0.10 8 ± 0.11
griseoflavin 14 ± 0.12 19 ± 0.15 16 ± 0.13
Each value is the mean of three replicate determinations ± standard deviation; C. a - Candida albicans;
A. n - Aspergillus niger; A. a – Alternaria alternata
Table 13. IC50 values DPPH radical scavenger results of synthesized compound (3a-3e).
Test compound IC 50 µg/ml values DPPH assay
3a 85.03 ± 0.19
3b 88.62 ± 0.10
3c 91.25 ± 0.05
3d 61.88 ± 0.01
Shaik Ammaji, Cheekurthi Sunddep, Koduru Sandeep, Kunchala Ashok, Kancharala Praveen, Badugu Sai Murali
Page | 912
Test compound IC 50 µg/ml values DPPH assay
3e 64.43 ± 0.00
BHT 95.25 ± 0.05
Each value is expressed as mean ± SD of three replicates; Stda BHT used as standard for DPPH radical scavenging activity.
The active lead molecules detected by using insilico
databases. The above results of insilico databases the compound
act as active lead molecule so they used to synthesis so many
heterocyclic derivatives, directly evaluate the biological activity.
From the antimicrobial results 3a, 3c, 3e compounds shows
excellent anti bacterial activity, 3b, 3d show excellent anti fungal
activity remain compounds show moderate activity, the 3a, 3b, 3c
shows good anti oxidant activity by DPPH method the values are
nearer to standard drug value.
4. CONCLUSIONS
Disubstitutedchalcones were combined from the beginning
material of di substituted ketone, it hasone electron pulling back
gathering and one electron discharging gathering. These mixes
described by IR, NMR, MASS. the aftereffects of insilico
databases all the compound go about as dynamic lead atom so they
straightforwardly assess for its organic action The mixes have
brilliant antimicrobial and against oxidant action the qualities are
closer to standard medication esteem. At long last reason that in
future these chalconetookas a middle of the road to combination
pyrazole, imidazole, quinoline, thiazole subordinates and assess
distinctive organic exercises.
5. REFERENCES
1. Elavarasan, M.; Thendral, M.T.; Shafi, S.S.Ayntheisis and
biological evaluation of chalcone derivatives. Inter jour pharm
scien and research 2018, 9, 1969-1973,
https://doi.org/10.13040/IJPSR.0975-8232.9(5).1969-73.
2. Ni, L.; Meng, C.Q.; Sikorski, J.A. Recent advances in
therapeutic chalcones. Expert Opinion on Therapeutic Patents
2004, 14, 1669-1691,
https://doi.org/10.1517/13543776.14.12.1669.
3. Sahu, N.K.; Balbhadra, S.S.; Choudhary, J.; Kohli, D.V.
Exploring pharmacological significance of chalcone scaffold: A
review. Curr. Med. Chem.2012, 19, 209–
225,https://doi.org/10.2174/092986712803414132.
4. Gomes, M.N.; Muratov, E.N.; Pereira, M.; Peixoto, J.C.;
Rosseto, L.P.; Cravo, P.V.L.; Andrade, C.H.; Neves, B.J.
Chalcone Derivatives: Promising Starting Points for Drug
Design. Molecules 2017, 22, 1210,
https://doi.org/10.3390/molecules22081210.
5. Evranos, A.B.; Ertan, R. Chemical and structural properties
of chalcones I. FABAD J. Pharm. Sci.2011, 36, 223–242.
6. Kim, D.W.; Curtis-Long, M.J.; Yuk, H.J.; Wang, Y.; Song,
Y.H.; Jeong, S.H.; Park, K.H. Quantitative analysis of phenolic
metabolites from different parts of Angelica keiskei by HPLC–
ESI MS/MS and their xanthine oxidase inhibition. Food
Chem.ol2014,153,20–27.
http://dx.doi.org/10.1016/j.foodchem.2013.12.026. 7. Yamamoto, T.; Yoshimura, M.; Yamaguchi, F.; Kouchi, T.;
Tsuji, R.; Saito, M.; Obata, A.; Kikuchi, M. Anti-allergic activity
of naringeninchalcone from a tomato skin extract. Biosci.
Biotechnol. Biochem.2004, 68, 1706–
171,https://doi.org/10.1271/bbb.68.1706.
8. Aoki, N.; Muko, M.; Ohta, E.; Ohta, S. C-
geranylatedchalcones from the stems of Angelica keiskei with
superoxide-scavenging activity. J. Nat. Prod.2008, 71, 2008,
1308–1310,https://doi.org/10.1021/np800187f.
9. Birari, R.B.; Gupta, S.; Mohan, C.G.; Bhutani, K.K.
Antiobesity and lipid lowering effects of Glycyrrhizachalcones:
Experimental and computational studies. Phytomedicine2011,
18, 795–801, https://doi.org/10.1016/j.phymed.2011.01.002.
10. Chen, M.; Christensen, S.B.; Blom, J.; Lemmich, E.;
Nadelmann, L.; Fich, K.; Theander, T.G.; Kharazmi, A.
Licochalcone A, a novel antiparasitic agent with potent activity
against human pathogenic protozoan species of Leishmania.
Antimicrob. Agents Chemother. 1993, 37, 2550–2556,
https://dx.doi.org/10.1128%2Faac.37.12.2550.
11. Cho, S.; Kim, S.; Jin, Z.; Yang, H.; Han, D.; Baek, N.I.; Jo,
J.; Cho, C.W.; Park, J.H.; Shimizu, M.; Jin,
Y.H.Isoliquiritigenin, a chalcone compound, is a positive
allosteric modulator of GABA A receptors and shows hypnotic
effects. Biochem.Biophys. Res. Commun. 2011,413, 637–
642,https://doi.org/10.1016/j.bbrc.2011.09.026.
12. Fowler, K.; Fields, W.; Hargreaves, V.; Reeve, L.; Bombick,
B. Development, qualification, validation and application of the
Ames test using a VITROCELL® VC10® smoke exposure
system. Toxicology Reports 2018, 5, 542-551,
https://doi.org/10.1016/j.toxrep.2018.04.003.
13. Dillon, D.; Combes, R.; Zeiger, E. The effectiveness of
Salmonella strains TA100, TA102 and TA104 for detecting
mutagenicity of some aldehydes and peroxides. Mutagenesis
1998, 13, 19-26, https://doi.org/10.1093/mutage/13.1.19.
14. Miller, W.H.; Dessert, A.M.; Roblin,
jr.R.O.heterocyclicsulphonamides as a cabonic anhydrase
inhibitors. J. Am. Chem. Soc.1950,72,4893-4896,
https://doi.org/10.1021/ja01167a012.
15. Sushko, I.; Novotarskyi, S.; Korner, R.; Pandey, A.K.; Rupp,
M.; Teetz, W.; Brandmaier, S.; Abdelaziz, A.; Prokopenko,
V.V.; Tanchuk, V.Y.; Todeschini, R.; Varnek, A.; Marcou, G.;
Ertl, P.; Potemkin, V.; Grishina, M.; Gasteiger, J.; Schwab, C.;
Baskin, II; Palyulin, V.A.; Radchenko, E.V.; Welsh, W.J.;
Kholodovych, V.; Chekmarev, D.; Cherkasov, A.; Aires-de-
Sousa, J.; Zhang, Q.Y.; Bender, A.; Nigsch, F.; Patiny, L.;
Williams, A.; Tkachenko, V.; Tekto, I.V. Online chemical
modeling environment (OCHEM): web platform for data
storage, model development and publishing of chemical
information. Journal of computer-aided molecular design 2011,
25, 533-554, https://doi.org/10.1007/s10822-011-9440-2.
16. Aniceto, N.; Freitas, A.A.; Bender, A.; Ghafourian, T. A
novel applicability domain technique for mapping predictive
reliability across the chemical space of a QSAR: reliability-
density neighbourhood. Journal of Cheminformatics 2016, 8, 69,
https://doi.org/10.1186/s13321-016-0182-y.
17. Honda, H.; Minegawa, K.; Fujita, Y.; Yamaguchi, N.;
Oguma, Y.; Glatt, H.; Nishiyama, N.; Kasamatsu, T. Modified
Ames test using a strain expressing human sulfotransferase 1C2
to assess the mutagenicity of methyleugenol. Genes and
In silico toxicity prediction, synthesis, characterization, antimicrobial and antioxidant activity of different di substituted
chalcones
Page | 913
Environment 2016, 38, 1, https://doi.org/10.1186/s41021-016-
0028-x.
18. de Mello Silva Oliveira, N.; Reis Resende, M.; Alexandre
Morales, D.; de RagãoUmbuzeiro, G.; Boriollo, M.F.G. In vitro
mutagenicity assay (Ames test) and phytochemical
characterization of seeds oil of Helianthus annuusLinné
(sunflower). Toxicology reports 2016, 3, 733-739,
https://doi.org/10.1016/j.toxrep.2016.09.006.
19. Prival, M.J.; Zeiger, E. Chemicals mutagenic in Salmonella
typhimurium strain TA1535 but not in TA100. Mutation
research 1998, 412, 251-260, https://doi.org/10.1016/s1383-
5718(97)00196-4.
20. Daina, A.; Michielin, O.; Zoete, V. SwissADME: a free web
tool to evaluate pharmacokinetics, drug-likeness and medicinal
chemistry friendliness of small molecules. Scientific reports
2017, 7, 42717, https://doi.org/10.1038/srep42717.
21. Claxton, L.D.; UmbuzeiroGde, A.; DeMarini, D.M. The
Salmonella mutagenicity assay: the stethoscope of genetic
toxicology for the 21st century. Environmental health
perspectives 2010, 118, 1515-1522,
https://doi.org/10.1289/ehp.1002336.
22. Sashidhara, K.V.; Rosaiah, J.N.; Kumar, A. Iodine-Catalyzed
Mild and Efficient Method for the Synthesis of Chalcones.
Synthetic Communications 2009, 39, 2288-2296,
https://doi.org/10.1080/00397910802654724.
23. Mojžiš, J.; Sarisský, M.; Pilatova, M.; Voharová, V.;
Varinska, L.; Mojzisová, G.; Ostro, A.; Urdzik, P.; Dankovcik,
R.; Mirossay, L. In vitro antiproliferative and antiangiogenic
effects of Flavin7®. Physiological research / Academia
ScientiarumBohemoslovaca2008, 57, 413-420.
24. Kulathooran. S.; Dhamodaran, M. Synthesis And Biological
Evaluation Of Some New Chalcones Using Anhydrous
Potassium Carbonate As An Efficient Basic Catalyst By
Conventional And Microwave Assisted Techniques.Ijpsr2015,
47, 3027-33.
25. Braca, A.; De Tommasi, N.; Di Bari, L.; Pizza, C.; Politi, M.;
Morelli, I. Antioxidant principles from Bauhinia tarapotensis.
Journal of natural products 2001, 64, 892-895,
https://doi.org/10.1021/np0100845.
26. Khalil, N.S. Efficient synthesis of novel 1,2,4-triazole fused
acyclic and 21-28 membered macrocyclic and/or lariat
macrocyclicoxaazathia crown compounds with potential
antimicrobial activity. Eur J Med Chem2010, 45, 5265-5277,
https://doi.org/10.1016/j.ejmech.2010.08.046.
27. Dhorajiya, B.D.;Dholakiya, B.Z. Design, Synthesis and
Comparative Study of Anti-Microbial Activities on Barbituric
Acid and Thiobarbituric Acid based Chalcone Derivatives
Bearing the Pyrimidine Nucleus.ChemSci J2016,7, 1-9.
28. Opletalova, V.; Jahodar, L.; Jun, D.; Opletal, L. [Chalcones
(1,3-diarylpropen-1-ones) and their analogs as potential
therapeutic agents in cardiovascular system diseases]. Ceska a
Slovenskafarmacie :casopis Ceske farmaceutickespolecnosti a
Slovenskefarmaceutickespolecnosti2003, 52, 12-19.
29. Sambamoorthy, U.; Venkataraju, M.; Manjappa, A.; Rao, M.
Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved
Pharmacokinetic and Biodistribution Profile. Current Drug
Delivery 2018, 15,
https://doi.org/10.2174/1567201815666181024112252.
30. Khan, S.A.; Asiri, A.M. Green synthesis, characterization
and biological evaluation of novel chalcones as anti bacterial
agents. Arabian Journal of Chemistry 2017, 10, S2890-S2895,
https://doi.org/10.1016/j.arabjc.2013.11.018.
31. Kurt, B.Z.; OztenKandas, N.; Dag, A.; Sonmez, F.;
Kucukislamoglu, M. Synthesis and biological evaluation of
novel coumarin-chalcone derivatives containing urea moiety as
potential anticancer agents. Arabian Journal of Chemistry 2020,
13, 1120-1129, https://doi.org/10.1016/j.arabjc.2017.10.001.
32. Seema, I.H. Chemical and biological potential of chalcones
as a source of drug.Ijppr2018, 11,104-118.
33. Baluja, S.; Vakariya, N.; Hirapara, A.Synthesis,
phytochemical studies of vanillin chalcones.
Scientific research2018, 47, 185-215,
http://dx.doi.org/10.15446/rcciquifa.v47n2.73966.
34. Deepika, P.; Maheswari, D.U.; Kumar, P.S.S.Chalcones as
Promising Antiproliferative Drug-A Review.Ijrsi2020, 7, 53.
35. Ardiansah, B. Chalcones bearing N, O, and S-heterocycles:
Recent notes on their biological significances. Journal of
Applied Pharmaceutical Science 2019, 9, 117-129,
https://doi.org/10.7324/JAPS.2019.90816.
36. Koudokpon, H.; Armstrong, N.; Dougnon, T.V.; Fah, L.;
Hounsa, E.; Bankole, H.S.; Loko, F.; Chabriere, E.; Rolain, J.M.
Antibacterial Activity of Chalcone and Dihydrochalcone
Compounds from Uvariachamae Roots against Multidrug-
Resistant Bacteria. BioMed research international 2018, 2018,
https://doi.org/10.1155/2018/1453173.
6. ACKNOWLEDGEMENTS
This research supported by Dr Y AnkammaChowdary, professor and principal of Nri College of pharmacy. We thank our
collegues who provide insight and expertise that greatly assisted the research.
© 2020 by the authors. This article is an open access article distributed under the terms and conditions of the
Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).